Obesity Clinical Trials

Find Obesity Clinical Trials Near You

Effects of a Collagen Supplement on Quality of Life, Appetite and Glycaemic Control: a Randomised, Double-blinded, Placebo-controlled, Crossover Trial in Overweight and Obese Adults.

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a clinical trial aimed to investigate if a collagen supplement can improve quality of life, appetite and blood sugar in overweight and obese adults aged 18-65. Hypothesis: Consumption of a collagen supplement for 8 days will improve quality of life and improve glycaemic control in comparison with a placebo in individuals overweight or with obesity with a perceived low quality of life. Participants will be asked to: 1. Consume a collagen peptide supplement for a total of 8 days at a time 2. Fill in questionnaires about quality of life, appetite, mood and energy 3. Wear continuous glucose monitors

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• Subject is a healthy (as assessed by medical history) male or female adult, aged 18-65 years and overweight or obese (BMI 25 - 40 kg/m2).

• Subject has an impaired quality of life, as determined by scoring at least a total of 9 on the following questions:

‣ In the past 4 weeks, did you feel you had a lot of energy? All of the time (1), most of the time (2), a good bit of the time (3), some of the time (4), a little of the time (5), and none of the time (6) (number 27 from SF-36 questionnaire) Version 3.0 \[01/10/2025\] Page 11 of 20

⁃ In the past 4 weeks, have you felt calm and peaceful? All of the time (1), most of the time (2), a good bit of the time (3), some of the time (4), a little of the time (5), and none of the time (6) (number 26 from SF-36 questionnaire)

⁃ In the past 2 weeks, did you have any difficulties with sleeping? Not at all (1), small amounts (2), moderate amounts (3), a great deal (4), an extreme amount (5), all the time (6) (number 3 from WHOQoL-100)

• Participant has an email address, internet access, a compatible smartphone and is willing and able to maintain internet access throughout the trial to complete virtual visits via video conference and to engage with mobile apps to answer electronic questionnaires.

• Subject is willing and able to comply with all study procedures, including consumption of the supplement daily, CGM use for 22 days total (2 x 11 days), complete standardised meal tests, and fill out health questionnaires.

• Subject is willing to take a supplement of bovine animal origin.

• Openness to participate in an online interview at the end of the study.

Locations
Other Locations
United Kingdom
Metabolic Research Unit (KCL, Waterloo Campus)
RECRUITING
London
Contact Information
Primary
Alex Cheok, PhD
alex.cheok@kcl.ac.uk
+442078480313
Backup
Ana Rodriguez-Mateos, PhD
ana.rodriguez-mateos@kcl.ac.uk
Time Frame
Start Date: 2025-12
Estimated Completion Date: 2027-01
Participants
Target number of participants: 100
Treatments
Experimental: Collagen peptide then placebo
2 x 5g of hydrolysed collagen peptide daily for 8 days then crossing over to the placebo
Experimental: Placebo then collagen peptide
2 x 5g of maltodextrin daily for 8 days then crossing over to the collagen peptide
Related Therapeutic Areas
Sponsors
Leads: King's College London
Collaborators: Rousselot BVBA

This content was sourced from clinicaltrials.gov